Edwin Kania

Mr. Kania has taken an active role in the launch and development of numerous biotechnology and biopharmaceutical companies during his 35 years in the venture capital industry. He is the managing partner of FarField Partners, a personal investment and advisory firm, and the co-founder and former Chairman of Flagship Ventures (now Flagship Pioneering), one of the largest venture capital firms launching and investing in U.S. biotechnology companies. He continues as co-managing partner for several Flagship Funds and as an advisory partner to the firm. Mr. Kania has served on the boards of dozens of public and private companies including Acceleron Pharma, Adolor Corp., Anesta Corp., ChemGenics Pharmaceuticals, Cytyc Corp., EXACT Sciences, IDEXX Laboratories, PerSeptive Biosystems, Somatogen, and Visterra. He is currently a director for Health Data Analytics Institute, Korrus/EcoSense, DataCore and TransMedics. Mr. Kania received a master’s degree from Harvard Business School and bachelor’s degree in Physics from Dartmouth College.